Muna Adam/LinkedIn
Jul 24, 2026, 08:57
Muna Adam: Plasma-Derived Factor X Concentrate Used in First UAE Roma Variant Cases
Muna Adam, Clinical Hematologist at Sheikh Shakhbout Medical City, shared a post on LinkedIn:
“Proud to have presented my Poster at ISTH 2026 in Paris.
‘Type II Factor X Deficiency Due to the Roma Variant (p.Thr358Met): First Reported Cases from the United Arab Emirates Treated with Plasma-Derived Factor X Concentrate.’
Grateful for the opportunity to contribute to the global rare bleeding disorders community.”
Stay updated with Hemostasis Today.
-
Jul 24, 2026, 08:58Aryabhatta Sadhu: Advancing Patient Blood Management with Rational Transfusion
-
Jul 24, 2026, 08:58Vikash Jaiswal: Toward Better ASCVD Risk Assessment for South Asian Populations
-
Jul 24, 2026, 08:57Wolfgang Miesbach: Human Tissue Study Sheds Light on AAV Gene Therapy Safety
-
Jul 24, 2026, 08:32Cedric Stephane Fosso: Every Drop of Blood Matters – A Child’s Silent Cry for Hemophilia Awareness
-
Jul 24, 2026, 08:19Afila Thasnim EK: Blood Grouping Discrepancies – A Critical Challenge in Transfusion Medicine
-
Jul 24, 2026, 05:15Jade Morrissey: Grateful to Present My PhD Research in Immunothrombosis at ISTH 2026
-
Jul 24, 2026, 05:04Moustafa Abdou: Unmasking Pure Red Cell Aplasia
-
Jul 24, 2026, 04:53Ana Pedrero Gil: The Future of Blood-Derived Therapies
-
Jul 24, 2026, 04:50Marc Wittwer: How We’re Making Hemostasis Diagnostics Faster, Simpler, and More Ergonomic